Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

Publisher： Karger

E-ISSN： 1423-0232|78|1|154-166

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.1, 2010-07, pp. : 154-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-07 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada

By Muszbek Noemi   Shah Sonalee   Carroll Stuart   McDonald Heather   Dale Peter   Maroun Jean   Knox Jennifer  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3559-3569

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Education and Imaging

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 438-438

John Wiley & Sons Inc

Access to resources Recommend Favorite